Lu-DOTATATE
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Lu-DOTATATE, covering 2025-12-03 to 2026-01-09. Get the full timeline:
Most recent: Clinical Trial Update: Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors [Phase 1]